The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis | BMC Cancer | Full Text

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis | BMC Cancer | Full Text

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis

Immunotherapy has become an essential part of cancer treatment after showing great efficacy in various malignancies. However, its effectiveness in pancreatic ductal adenocarcinoma (PDAC), especially in resecta...

Authors:Saber Amin, Michael Baine, Jane Meza and Chi Lin

Citation:BMC Cancer 2020 20:538

Content type:Research article

 

Published on: 9 June 2020

• ViewFull Text
 
• ViewPDF